We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Most Oxytocin studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality meta-analyses and randomised trials published 2000–2022 with a typical study size of 52 participants.
Based on 12 studies · 6 meta-analyses · 5 RCTs · 367 total participants
Confidence
High
By outcome
Social cognition & behaviour
Mostly mechanism / observational8 studies
Mood, anxiety & psychiatric
Mostly mechanism / observational4 studies
Labor, postpartum & lactation
Too few graded studies2 studies
Safety & adverse effects
Too few graded studies2 studies
Steady research
3 studies in the last 5 years · Latest meta-analysis: 2022
200020112022
1RCTn=290 · medium study2021
This placebo-controlled trial of intranasal oxytocin therapy in children and adolescents with autism spectrum disorder showed no significant between-group differences in measures of social or cognitive functioning.
Sikich L, Kolevzon A, King BH, et al. · N Engl J Med (2021)
Prophylactic oxytocin compared with placebo reduced the risk of PPH greater than 500 mL, (risk ratio (RR) 0.53; 95% confidence interval (CI) 0.38 to 0.74; six trials, 4203 women...) and the need for therapeutic uterotonics (RR 0.56; 95% CI 0.36 to 0.87, four trials, 3174 women...).
Cochrane systematic review and meta-analysis of 20 randomized/quasi-randomized trials (10,806 women) of prophylactic oxytocin in the third stage of labour
Prophylactic oxytocin roughly halved the risk of PPH >500 mL versus placebo (RR 0.53, 95% CI 0.38-0.74) and reduced the need for therapeutic uterotonics (RR 0.56)
Oxytocin was superior to ergot alkaloids for preventing PPH >500 mL with fewer side effects (less nausea/vomiting), and did not increase retained-placenta risk
IN-OT had no significant effect on emotion recognition, a moderate but non-significant effect on empathy, and a small, significant effect on theory of mind.
Keech B, Crowe S, Hocking DR. · Psychoneuroendocrinology (2018)
Meta-analysis of 17 RCTs (466 participants with neurodevelopmental disorders)
No significant effect on emotion recognition; only a small significant effect on theory of mind (Hedges' g=0.21)
Effect not moderated by diagnosis, age, dose, or dosing frequency
Repeated administration of intranasal OT does not improve most of the core symptoms of schizophrenia and ASD, beyond a small tentative effect on schizophrenia general symptoms.
Martins D, Paduraru M, Paloyelis Y. · Br J Pharmacol (2022)
Meta-analysis (including variance/meta-ANOVA) of repeated intranasal oxytocin in schizophrenia and ASD
No improvement on most core symptoms; only a small tentative effect on schizophrenia general symptoms
Signals of response heterogeneity suggest possible responder/non-responder subgroups, not a robust average effect
This study was the first to investigate the efficacy of an extended treatment of oxytocin nasal spray combined with social cognition training to improve social cognition, clinical symptoms, and social functioning in early psychosis.
Intranasal administration of oxytocin... causes a substantial increase in trust among humans... oxytocin specifically affects an individual's willingness to accept social risks arising through interpersonal interactions.
Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. · Nature (2005)
Placebo-controlled experiment: single-dose intranasal oxytocin increased trusting behaviour in an economic trust game
Effect attributed to willingness to take social (not general) risk
The foundational, widely-cited 'love hormone' study that launched the field
Subjects in the oxytocin group show no change in their trusting behavior after they learned that their trust had been breached... associated with a specific reduction in activation in the amygdala, the midbrain regions, and the dorsal striatum.
Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E. · Neuron (2008)
Double-blind intranasal oxytocin + fMRI trust-game study
Oxytocin blunted the normal reduction in trust after betrayal, with reduced amygdala/midbrain/striatal activation
Mechanistically informative for the social-salience hypothesis
Several useful oxytocin induction protocols are available... The most important risks include hyperstimulation, failed induction, and uterine rupture in some studies.
Stubbs TM. · Clin Obstet Gynecol (2000)
Clinical review of oxytocin protocols for labor induction (the established, approved medical use)
Higher-dose protocols reduce cesarean for dystocia but increase fetal-distress signals — a managed trade-off
Key risks: uterine hyperstimulation (common, usually brief), failed induction, and rare uterine rupture